Does type 2 diabetes predispose to osteoporotic bone fractures?;Czy cukrzyca typu 2 predysponuje do osteoporotycznych złamań kości?

Endokrynologia Polska

Volumn 59, Issue 3, 2008, Pages 224-229

  Miazgowski, Tomasz ^a   Krzyzanowska Świniarska, Barbara ^a   Ogonowski, Jarosław ^a   Noworyta Zietara, Marzena ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Bone mineral density; Diabetes; Osteoporosis

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOOP DIURETIC AGENT; ORGANIC NITRATE; THIAZIDE DIURETIC AGENT;

BODY MASS; BONE DENSITY; BRAIN ISCHEMIA; DIABETIC RETINOPATHY; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; FALLING; FRAGILITY FRACTURE; HEART MUSCLE ISCHEMIA; HIP FRACTURE; HUMAN; HYPERTENSION; LEG ISCHEMIA; MUSCLE HYPOTONIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PHYSICAL ACTIVITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; VISUAL IMPAIRMENT; VITAMIN INTAKE;

ACCIDENTAL FALLS; CAUSALITY; COMORBIDITY; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FRACTURES, BONE; HIP FRACTURES; HUMANS; OSTEOPOROSIS; RISK ASSESSMENT;

EID: 52249101520     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. De Liefde II, van der Klift M, de Laet CE i wsp. Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study. Osteoporos Int 2005; 16: 1713-1720.
2. Isaia GC, Ardissone P, Di Stefano M i wsp. Bone metabolism in type 2 diabetes mellitus. Acta Diabetol 1999; 36: 35-38.
3. Majima T, Komatsu Y, Yamada T i wsp. Decreased bone mineral density at the distal radius, but not at the lumbar spine or the femoral neck, in Japanese type 2 diabetic patients. Osteoporos Int 2005; 16: 907-913.
4. Gunczler P, Lanes R, Paoli M, Martinis R, Villaroel O, Weisinger JR. Decreased bone mineral density and bone formation markers shortly after diagnosis of clinical type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001; 4: 525-528.
5. Hofbauer LC, Brueck CC, Singh SK i wsp, Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007; 22: 1317-1328.
6. Janghorbani M, Van Dam RM, Willett WC i wsp. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol 2007; 166: 495-505.
7. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients its with type 1 and type 2 diabetes - a meta-analysis. Osteoporos Int 2007; 18: 427-444.
8. Vashishth D, Gibson GJ, Khoury JI i wsp. Influence of nonenzymatic glycation on biochemical properties of cortical bone. Bone 2001; 28: 195-201.
9. McCarthy AD, Etcheverry SB, Cortizo AM. Effect of advanced glycation end products on the secretion of insulin-like growth factor-I and its binding proteins: role in osteoblast development. Acta Diabetol 2001; 38: 113-122.
10. Kanazawa I, Yamaguchi T, Yamamoto M i wsp. Serum insulin-like growth factor-I is associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes mellitus. Osteoporos Int 2007; 18: 1675-1681.
11. Cutrim, DM, Pereira FA, de Paula FJA i wsp. Lack of relationship between glycemic control and bone mineral density in type 2 diabetes mellitus. Braz J Med Biol Res 2007; 40: 221-227.
12. Strotmeyer ES, Cauley JA, Schwartz AV i wsp. Diabetes is associated independently of body composition with BMD and bone volume in older white and black men and women: The Health, Aging, and Body Composition Study. J Bone Miner Res 2004; 19: 1084-1091.
13. Khosla S, Atkinson EJ, Riggs BL i wsp. Relationship between body composition and bone mass in women. J Bone Miner Res 1996; 11: 857-863.
14. Pongchaiyakul C, Nguyen ND, Pisprasert V i wsp. A meta-analysis of relationships among leptin, fat mass, lean mass, and bone mineral density. J Bone Miner Res 2005; 20 (supl. 1): S261.
15. Reid IR. Relationships between fat and bone. Osteoporos Int. 2008; 19: 595-606. Epub 2007.
16. Revilla M, Villa LF, Sanchez-Atrio A i wsp. Influence of body mass index on the age-related slope of total and regional bone mineral content. Calcif Tissue Int 1997; 61: 134-138.
17. Dennison EM, Syddall HE, Aihie Sayer A i wsp. Type 2 diabetes mellitus is associated with increased axial bone density in men and women from the Hertfordshire Cohort Study: evidence for an indirect effect of insulin resistance? Diabetologia 2004; 47: 1963-1968.
18. Cornish J, Callon KE, Bava U i wsp. Effects of calcitonin, amylin and calcitonin gene related peptide on osteoclast development. Bone 2001; 29: 162-168.
19. Yatagai T, Nagasaka S, Taniguchi A i wsp. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 2003; 52: 1274-1278.
20. Lindsay RS, Funahashi T, Hanson RL i wsp. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002; 360: 57-58.
21. Berner HS, Lyngstadaas SP, Spahr A i wsp. Adiponectin and its receptors are expressed in bone forming cells. Bone 2004, 35: 842-849.
22. Richards JB, Valdes AM, Burling K i wsp. Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab 2007; 92: 1517-1523.
23. Jürimäe J, Jürimäe T. Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporos Int 2007; 18: 1253-1259.
24. Luo XH, Guo LJ, Xie H i wsp. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 2006; 21: 1648-1656.
25. Hamrick MW. Leptin and bone: a consensus emerging? BoneKEy-Osteovision 2007; 4: 99-107. http://www.bonekey-ibms.org/cgi/content/full/ibmske;4/3/ 99.
26. Cornish J, Callon KE, Bava U i wsp. Preptin, another peptide product of the pancreatic beta cell, is osteogenic in vitro and in vivo. Am J Physiol Endocrinol Metab 2007; 292: 117-122.
27. Cornish J, Callon KE, Watson M i wsp. Resistin, an adipocytokine, stimulates osteoblast and osteoclast proliferation. Bone 2006; 38 (supl. 1): 9.
28. Kempa A, Krzyzanowska-Świniarska B, Miazgowski T i wsp. Not insulin but insulin sensivity, leptin and cortisol are major factors regulating serum acylated ghrelin level in healthy women. J Endocrinol Invest 2007; 30: 659-665.
29. Kim SW, Her SJ, Park SJ i wsp. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 2005; 37: 359-369.
30. Williams JP, Blair HC, McDonald JM i wsp. Regulation of osteoclastic bone resorption by glucose. Biochem Biophys Res Commun 1997; 235: 646-651.
31. Clowes JA, Robinson RT, Heller SR i wsp. Acute changes of bone turnover and PTH induced by insulin and glucose: Euglycemic and hypoglycemic hyperinsulinemic clamp studies. J Clin Endocrinol Metab 2002; 87: 3324-3329.
32. Scragg R, Haldaway I, Singh V i wsp. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995; 27: 181-188.
33. Wakasugi M, Wakao R, Tawa ta M i wsp. Bone mineral density measured by dual energy x-ray absorptiometry in patients with non-insulin-dependent diabetes mellitus. Bone 1993; 14: 29-33.
34. Perez-Castrillon JL, De Luis D, Martin-Escudero JC i wsp. Non-insulin-dependent diabetes, bone mineral density, and cardiovascular risk factors. J Diabetes Complications 2004; 18: 317-321.
35. Forsen L, Meyer LJ, Midthjell K i wsp. Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trondelag Health Survey. Diabetologia 1999; 42: 920-925.
36. Ivers RQ, Cumming RG, Mitchell P i wsp. Diabetes and risk of fracture: The Blue Mountain Eye Study. Diabetes Care 2001; 24: 1198-1203.
37. Nicodemus KK, Folsom AR. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women. Diabetes Care 2001; 24: 1192-1197.
38. Schwartz AV, Sellmeyer DE, Ensrud H i wsp. Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab 2001; 86: 32-38.
39. Ottenbacher KJ, Ostir GV, Peek MK i wsp. Diabetes melhtus as a risk factor for hip fracture in Mexican-American older adults. J Gerontol A Biol Sci Med Sci 2002; 57: M648-M653.
40. Strotmeyer ES, Cauley JA, Schwartz AV i wsp. Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: The Health, Aging, and Body Composition Study. Arch Intern Med 2005; 165: 1612-1617.
41. Gerdhem P, Isaksson A, Akesson K i wsp. Increased bone mineral density and decreased bone turnover, but no evident alternation of fracture susceptibility in elderly women with diabetes mellitus. Osteoporos Int 2005; 16: 1506-1512.
42. Holmberg AH, Johnell O, Nilsson PM i wsp. Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 2006; 17: 1065-1077.
43. Seeman E. An exercise in geometry. J Bone Miner Res 2002; 17: 373-378.
44. Janghorbani M, Feskanich D, Willet WC i wsp. Prospective study of diabetes mellitus and risk of hip fracture: The Nurses Health Study. Diabetes Care 2006; 29: 1573-1578.
45. Ahmed LA, Joakimsen RM, Berritsen GK i wsp. Diabetes mellitus and the risk of non-vertebral fractures: The Tromso Study. Osteoporos Int 2006; 17: 495-500.
46. Rejnmark L, Vestergaard P, Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int 2005; 76: 167-175.
47. Rejnmark L, Vestergaard P, Mosekilde L. Fracture risk in patients treated with loop diuretics. J Intern Med 2006; 117-124.
48. Rejnmark L, Vestergaard P, Mosekilde L. Statin but not non-statin hpid-lowering drugs decrease fracture risk: a nation-wide case-control study. Calcif Tissue Int 2006; 79: 27-36.
49. Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta-blockers, ACE inhibitors, and calcium-channel blackers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens 2006; 24: 581-589.
50. Rejnmark L, Vestergaard P, Mosekilde L. Decreased fracture risk in users of organic nitrates: a nationwide case-control study. J Bone Miner Res 2006; 21: 1811-1817.
51. Monami M, Cresci B, Colombini A i wsp. Bone fractures and hypoglycaemic treatment in type 2 diabetic patients: a case-control study. Diabetes Care 2007, DOI: 10.2337/dc07-1736.
52. Sennerby U, Farahmand B, Ahlbom A i wsp. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int 2007; 18: 1355-1362.